...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: BIO Investor Forum, Oct 22-23
Reply New Message
Back To Forum List View

BIO Investor Forum. October 22 - 23, 2019, San Francisco, California

Resverlogix and Zenith both on the presenting companies list for Wednesday October 23.

https://www.bio.org/events/bio-investor-forum

6 Recommendations
Icon president Re: BIO Investor Forum, Oct 22-23
4
BearDownAZ
Oct 17, 2019 02:41PM
Re: BIO Investor Forum, Oct 22-23
4
narmac
Oct 18, 2019 10:40AM
Icon president Re: BIO Investor Forum, Oct 22-23
6
BearDownAZ
Oct 18, 2019 01:01PM
Re: BIO Investor Forum, Oct 22-23
3
narmac
Oct 18, 2019 02:05PM
Re: BIO Investor Forum, Oct 22-23
2
iconoclast
Oct 21, 2019 06:01PM
Icon president Re: BIO Investor Forum, Oct 22-23
4
BearDownAZ
Oct 23, 2019 06:38PM
Re: BIO Investor Forum, Oct 22-23
3
narmac
Oct 24, 2019 11:14AM
Icon president Re: BIO Investor Forum, Oct 22-23
2
Toinv
Oct 24, 2019 04:18PM
Icon president Re: BIO Investor Forum, Oct 22-23
1
Toinv
Oct 24, 2019 04:42PM
Re: BIO Investor Forum, Oct 22-23
1
narmac
Oct 24, 2019 06:04PM
Icon president Re: BIO Investor Forum, Oct 22-23
2
Toinv
Oct 24, 2019 07:51PM
Icon president Re: BIO Investor Forum, Oct 22-23
6
BearDownAZ
Oct 24, 2019 11:40PM
Re: BIO Investor Forum, Oct 22-23
6
RVXoldtimer
Oct 25, 2019 11:42AM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply